top of page

Our Collaborators

Endurion Therapeutics LLC, collaborates with experts in oncology and pulmonary disease with our lead compound, ORIN1001.

Investors Welcome

Endurion Therapeutics LLC, is actively seeking investors for Phase 2 trials in oncology, IPF, and other serious diseases with ORIN1001. 

Modern Architecture

COLLABORATORS

  • Dr. Mothaffar Rimawi

Medical Director of the Lester and Sue Smith Breast Center; Baylor College of Medicine, Houston Texas

  • Dr. Laurie Glimcher

Former President and CEO of Dana-Farber Cancer Institute from 2016 to 2024 and the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School. ​​​

  • Dr. Juan Cubillos-Ruiz

Professor of Microbiology and Immunology, Weill Cornell Medicine​

  • ​Dr. Xi Chen​

Assistant Professor, MD Anderson, Houston Texas

  • Dr. Afshin Somali

Professor, University of Galway, Ireland

  • Dr. Fahri Saatclogui

Professor for Molecular and Cell Biology, University of Oslo, Norway

  • Dr. Timothy Blackwell

Professor, Vanderbilt University, Nashville, Tennessee

  • Dr. Kenneth Anderson

Dana Farber Canter;  Program Director, Jerome Lipper Multiple Myeloma Center;  Kraft Family Professor of Medicine, Harvard Medical School

  • Dr. Eric Chevet

Research Director, French National Institute for Health and Medical Research (Inserm)

bottom of page